Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival

被引：0
|
作者：
El-Magd, Gehan H. Abo
Abd El-Fattah, Omnia
Saied, Eman M.
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Lung cancer / Oncology; Bronchoscopy;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P512
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer
    Donias, HW
    Karamanoukian, HL
    D'Ancona, G
    Hoover, EL
    ANNALS OF SURGERY, 2002, 235 (03) : 446 - 446
  • [22] Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
    Katsuhiko Shimizu
    Takuro Yukawa
    Riki Okita
    Shinsuke Saisho
    Ai Maeda
    Yuji Nojima
    Masao Nakata
    World Journal of Surgical Oncology, 13
  • [23] Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
    Shimizu, Katsuhiko
    Yukawa, Takuro
    Okita, Riki
    Saisho, Shinsuke
    Maeda, Ai
    Nojima, Yuji
    Nakata, Masao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [24] hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer
    Wang, L
    Soria, JC
    Kemp, BL
    Liu, DD
    Mao, L
    Khuri, FR
    CLINICAL CANCER RESEARCH, 2002, 8 (09) : 2883 - 2889
  • [25] Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer
    Laga, AC
    Zander, DS
    Cagle, PT
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2005, 129 (09) : 1113 - 1117
  • [26] Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients
    Zhu Chihong
    Ling Yutian
    Wan Danying
    Jiang Ruibin
    Sheng Huaying
    Gu Linhui
    Feng Jianguo
    ONCOTARGET, 2017, 8 (28) : 45577 - 45584
  • [27] Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer
    Zhang, Xiaohong
    Wang, Hongmin
    Wang, Jing
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (04): : 350 - 355
  • [28] Prognostic value of microRNA expression in operable non-small cell lung cancer patients
    Skrzypski, M.
    Czapiewski, P.
    Goryca, K.
    Jassem, E.
    Wyrwicz, L.
    Pawlowski, R.
    Rzyman, W.
    Biernat, W.
    Jassem, J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 991 - 1000
  • [29] Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Kim, Anthony W.
    Batus, Marta
    Myint, Ronald
    Fidler, Mary J.
    Basu, Sanjib
    Bonomi, Philip
    Faber, L. Penfield
    Wightman, Sean C.
    Warren, William H.
    McIntire, Maria
    Arvanitis, Leonidas D.
    Gattuso, Paolo
    Xue, Xiulong
    Liptay, Michael J.
    LUNG CANCER, 2011, 71 (02) : 186 - 190
  • [30] Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer
    Kang, S
    Kim, YB
    Kim, MH
    Yoon, KS
    Kim, JW
    Park, NH
    Song, YS
    Kang, D
    Yoo, KY
    Kang, SB
    Lee, HP
    CANCER LETTERS, 2005, 217 (01) : 11 - 16
12345